Transaction · 0000874015-25-000017

Birchler Brian

Birchler Brian, EVP, CDO, reported a transaction classified as grant at IONIS PHARMACEUTICALS INC involving 22000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 22000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AEVP, CDO
IONSIONIS PHARMACEUTICALS INC
Filing timeJan 06
Trade dateJan 02, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2025-01-06Filed 605 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000874015-25-000017
Non-Qualified Stock Option (right to buy)
Transaction date
Jan 02, 2025
Filed Jan 06, 2025, 09:52 PM · 4d delay
Shares
22.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
22.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Corp and Development Ops

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Grant on 01/02/2025 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable a…

  2. 01/02/2025. 25% of the shares subject to the option will vest and become exercisable on 01/02/2026. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal…

Original filing · 0000874015-25-000017
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS